Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIronveld Regulatory News (IRON)

Share Price Information for Ironveld (IRON)

Share Price is delayed by 15 minutes
Get Live Data
0.021    0.00 (0.00%)
Bid:
0.02
Ask:
0.022
Spread: 0.002 (10.00%)
Market Cap: £4.35m
IRON Live PriceLast checked at - London Stock Exchange

Intraday Ironveld Share Chart

Director Dealing

1 Mar 2023 17:36

RNS Number : 5811R
Ironveld PLC
01 March 2023
 

1 March 2023

 

IRONVELD PLC

("Ironveld" or the "Company")

Director Dealing

Ironveld plc has been notified that Tracarta Limited, a company in which John Wardle, Non-Executive Director, has a beneficial interest, purchased 50,000,000 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 0.3150 pence per Ordinary Shares on 28 February 2023. The revised interest of Tracarta Limited in the Company's issued share capital is as follows:

Holding prior to Notification

Shares Acquired

Holding after Notification

Percentage of Existing Share capital

 

237,046,901

50,000,000

287,046,901

9.05

 

 

 

For further information, please contact:

Ironveld plc

Giles Clarke, Chairman

Martin Eales, Chief Executive Officer

 

c/o BlytheRay

+44 20 7138 3204

 

finnCap (Nomad and Joint Broker)

Christopher Raggett / Charlie Beeson

 

+44 20 7220 0500

Turner Pope (Joint Broker)

Andrew Thacker/James Pope

 

+44 20 3657 0050

BlytheRay

Tim Blythe / Megan Ray

+44 20 7138 3204

 

 

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dr John Wardle

2.

Reason for the Notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ironveld Plc

b)

LEI

2138004LU52LQBNXG604

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1 pence each in Ironveld plc

Identification code

GB0030426455

b)

Nature of the transaction

Acquisition of shares by Tracarta Limited

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.3150p

50,000,000

d)

Aggregated information:

·Aggregated volume

·Price

See above

e)

Date of the transaction

28 February 2023

f)

Place of the transaction

Outside trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHJBMRTMTJMBJJ
Date   Source Headline
3rd Sep 20207:00 amRNSFurther Extension of IIG Option Agreement
18th Aug 20202:53 pmRNSChange of Registered Office address
11th Jun 20207:00 amRNSBridge Loan Facility and Extension of IIG Option
27th May 20207:00 amRNSUpdate on IIG Option Agreement
23rd Apr 20208:09 amRNSBlocklisting Return
30th Mar 202010:30 amRNSInterim results
30th Mar 202010:00 amRNSStrategic Partnership and Conditional Fundraising
4th Feb 20209:21 amRNSNotification of Transaction
3rd Feb 20207:00 amRNSLoan Facilities Agreement
10th Jan 202012:45 pmRNSGrant of Share Options
10th Jan 202010:20 amRNSResult of AGM
24th Dec 20197:00 amRNSPublication of Annual Report and Notice of AGM
6th Dec 20197:00 amRNSAppointment of Chief Executive Officer ("CEO")
5th Dec 20197:00 amRNSFinal results for the year ended 30 June 2019
22nd Oct 20197:00 amRNSBlocklisting Return
30th Sep 20197:00 amRNSUpdate on Strategic Review
24th Sep 20197:00 amRNSDirectorate Change
19th Sep 20197:00 amRNSDirectorate Change
12th Aug 20197:00 amRNSUpdate on Strategic Review
16th Jul 20198:00 amRNSPublication of Research
2nd Jul 20197:00 amRNSStrategic Review
5th Jun 20197:00 amRNSUpdate on off-take discussions
23rd Apr 20197:00 amRNSBlocklisting Return
28th Mar 20197:00 amRNSInterim results for the 6 months ended 31 Dec 2018
19th Feb 20197:00 amRNSPlacing to raise £1.1 million
14th Feb 20197:00 amRNSUpdate on bulk sampling programme
18th Jan 201911:30 amRNSResult of AGM
18th Jan 20197:00 amRNSCompany Update
21st Dec 201810:25 amRNSNotice of AGM
7th Dec 20187:00 amRNSFinal results for the year ended 30 June 2018
19th Nov 20187:00 amRNSPlacing to raise £400,000
7th Nov 20182:15 pmRNSNotification of major holdings
22nd Oct 20187:00 amRNSBlock listing Interim Review
26th Sep 20187:00 amRNSIronveld supplies potential off-take partner
12th Jul 20185:02 pmRNSHolding(s) in Company
9th Jul 20187:00 amRNSDirector/PDMR Shareholding
23rd Apr 20187:00 amRNSBlocklisting Return
28th Mar 20187:00 amRNSInterim results for the 6 months ended 31 Dec 2017
28th Feb 20187:00 amRNSCompany Update
31st Jan 20189:00 amRNSHolding(s) in Company
23rd Jan 20185:18 pmRNSResult of AGM
23rd Jan 20189:45 amRNSTR-1: Notification of major holdings
19th Dec 20177:00 amRNSAppointment of Non-Executive Director
7th Dec 20177:00 amRNSFinal results for the year ended 30 June 2017
27th Nov 20177:00 amRNSPlacing to raise £1.765 million
30th Oct 201712:10 pmRNSHolding(s) in Company
23rd Oct 20177:00 amRNSBlocklisting Return
12th Oct 20177:00 amRNSCompany Update
4th Oct 201710:45 amRNSHolding(s) in Company
25th Jul 20179:07 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.